Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson's Disease Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Carbidopa/Levodopa
1.2.3 Dopamine Receptor Agonists
1.2.4 MAO-Inhibitors
1.3 Market by Application
1.3.1 Global Parkinson's Disease Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Parkinson's Disease Market Perspective (2018-2033)
2.2 Parkinson's Disease Growth Trends by Region
2.2.1 Global Parkinson's Disease Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Parkinson's Disease Historic Market Size by Region (2018-2023)
2.2.3 Parkinson's Disease Forecasted Market Size by Region (2024-2033)
2.3 Parkinson's Disease Market Dynamics
2.3.1 Parkinson's Disease Industry Trends
2.3.2 Parkinson's Disease Market Drivers
2.3.3 Parkinson's Disease Market Challenges
2.3.4 Parkinson's Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Parkinson's Disease Players by Revenue
3.1.1 Global Top Parkinson's Disease Players by Revenue (2018-2023)
3.1.2 Global Parkinson's Disease Revenue Market Share by Players (2018-2023)
3.2 Global Parkinson's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Parkinson's Disease Revenue
3.4 Global Parkinson's Disease Market Concentration Ratio
3.4.1 Global Parkinson's Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Revenue in 2022
3.5 Parkinson's Disease Key Players Head office and Area Served
3.6 Key Players Parkinson's Disease Product Solution and Service
3.7 Date of Enter into Parkinson's Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson's Disease Breakdown Data by Type
4.1 Global Parkinson's Disease Historic Market Size by Type (2018-2023)
4.2 Global Parkinson's Disease Forecasted Market Size by Type (2024-2033)
5 Parkinson's Disease Breakdown Data by Application
5.1 Global Parkinson's Disease Historic Market Size by Application (2018-2023)
5.2 Global Parkinson's Disease Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Parkinson's Disease Market Size (2018-2033)
6.2 North America Parkinson's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Parkinson's Disease Market Size by Country (2018-2023)
6.4 North America Parkinson's Disease Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Parkinson's Disease Market Size (2018-2033)
7.2 Europe Parkinson's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Parkinson's Disease Market Size by Country (2018-2023)
7.4 Europe Parkinson's Disease Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Parkinson's Disease Market Size (2018-2033)
8.2 Asia-Pacific Parkinson's Disease Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Parkinson's Disease Market Size by Region (2018-2023)
8.4 Asia-Pacific Parkinson's Disease Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Parkinson's Disease Market Size (2018-2033)
9.2 Latin America Parkinson's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Parkinson's Disease Market Size by Country (2018-2023)
9.4 Latin America Parkinson's Disease Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Parkinson's Disease Market Size (2018-2033)
10.2 Middle East & Africa Parkinson's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Parkinson's Disease Market Size by Country (2018-2023)
10.4 Middle East & Africa Parkinson's Disease Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Detail
11.1.2 Teva Business Overview
11.1.3 Teva Parkinson's Disease Introduction
11.1.4 Teva Revenue in Parkinson's Disease Business (2018-2023)
11.1.5 Teva Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Parkinson's Disease Introduction
11.2.4 Novartis Revenue in Parkinson's Disease Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Parkinson's Disease Introduction
11.3.4 GSK Revenue in Parkinson's Disease Business (2018-2023)
11.3.5 GSK Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Detail
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Parkinson's Disease Introduction
11.4.4 AbbVie Revenue in Parkinson's Disease Business (2018-2023)
11.4.5 AbbVie Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Parkinson's Disease Introduction
11.5.4 Merck Revenue in Parkinson's Disease Business (2018-2023)
11.5.5 Merck Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Detail
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Parkinson's Disease Introduction
11.6.4 Boehringer Ingelheim Revenue in Parkinson's Disease Business (2018-2023)
11.6.5 Boehringer Ingelheim Recent Development
11.7 Amneal + Impax
11.7.1 Amneal + Impax Company Detail
11.7.2 Amneal + Impax Business Overview
11.7.3 Amneal + Impax Parkinson's Disease Introduction
11.7.4 Amneal + Impax Revenue in Parkinson's Disease Business (2018-2023)
11.7.5 Amneal + Impax Recent Development
11.8 Lundbeck
11.8.1 Lundbeck Company Detail
11.8.2 Lundbeck Business Overview
11.8.3 Lundbeck Parkinson's Disease Introduction
11.8.4 Lundbeck Revenue in Parkinson's Disease Business (2018-2023)
11.8.5 Lundbeck Recent Development
11.9 Sun Pharma
11.9.1 Sun Pharma Company Detail
11.9.2 Sun Pharma Business Overview
11.9.3 Sun Pharma Parkinson's Disease Introduction
11.9.4 Sun Pharma Revenue in Parkinson's Disease Business (2018-2023)
11.9.5 Sun Pharma Recent Development
11.10 Wockhardt
11.10.1 Wockhardt Company Detail
11.10.2 Wockhardt Business Overview
11.10.3 Wockhardt Parkinson's Disease Introduction
11.10.4 Wockhardt Revenue in Parkinson's Disease Business (2018-2023)
11.10.5 Wockhardt Recent Development
11.11 UCB
11.11.1 UCB Company Detail
11.11.2 UCB Business Overview
11.11.3 UCB Parkinson's Disease Introduction
11.11.4 UCB Revenue in Parkinson's Disease Business (2018-2023)
11.11.5 UCB Recent Development
11.12 Bausch Health
11.12.1 Bausch Health Company Detail
11.12.2 Bausch Health Business Overview
11.12.3 Bausch Health Parkinson's Disease Introduction
11.12.4 Bausch Health Revenue in Parkinson's Disease Business (2018-2023)
11.12.5 Bausch Health Recent Development
11.13 Acadia
11.13.1 Acadia Company Detail
11.13.2 Acadia Business Overview
11.13.3 Acadia Parkinson's Disease Introduction
11.13.4 Acadia Revenue in Parkinson's Disease Business (2018-2023)
11.13.5 Acadia Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Parkinson's Disease Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Carbidopa/Levodopa
Table 3. Key Players of Dopamine Receptor Agonists
Table 4. Key Players of MAO-Inhibitors
Table 5. Global Parkinson's Disease Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Parkinson's Disease Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Parkinson's Disease Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Parkinson's Disease Market Share by Region (2018-2023)
Table 9. Global Parkinson's Disease Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Parkinson's Disease Market Share by Region (2024-2033)
Table 11. Parkinson's Disease Market Trends
Table 12. Parkinson's Disease Market Drivers
Table 13. Parkinson's Disease Market Challenges
Table 14. Parkinson's Disease Market Restraints
Table 15. Global Parkinson's Disease Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Parkinson's Disease Market Share by Players (2018-2023)
Table 17. Global Top Parkinson's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease as of 2022)
Table 18. Ranking of Global Top Parkinson's Disease Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Parkinson's Disease Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Parkinson's Disease Product Solution and Service
Table 22. Date of Enter into Parkinson's Disease Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Parkinson's Disease Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Parkinson's Disease Revenue Market Share by Type (2018-2023)
Table 26. Global Parkinson's Disease Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Parkinson's Disease Revenue Market Share by Type (2024-2033)
Table 28. Global Parkinson's Disease Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Parkinson's Disease Revenue Market Share by Application (2018-2023)
Table 30. Global Parkinson's Disease Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Parkinson's Disease Revenue Market Share by Application (2024-2033)
Table 32. North America Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Parkinson's Disease Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Parkinson's Disease Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Parkinson's Disease Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Parkinson's Disease Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Parkinson's Disease Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Parkinson's Disease Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Parkinson's Disease Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Parkinson's Disease Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Parkinson's Disease Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Parkinson's Disease Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Parkinson's Disease Market Size by Country (2024-2033) & (US$ Million)
Table 47. Teva Company Detail
Table 48. Teva Business Overview
Table 49. Teva Parkinson's Disease Product
Table 50. Teva Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
Table 51. Teva Recent Development
Table 52. Novartis Company Detail
Table 53. Novartis Business Overview
Table 54. Novartis Parkinson's Disease Product
Table 55. Novartis Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
Table 56. Novartis Recent Development
Table 57. GSK Company Detail
Table 58. GSK Business Overview
Table 59. GSK Parkinson's Disease Product
Table 60. GSK Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
Table 61. GSK Recent Development
Table 62. AbbVie Company Detail
Table 63. AbbVie Business Overview
Table 64. AbbVie Parkinson's Disease Product
Table 65. AbbVie Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
Table 66. AbbVie Recent Development
Table 67. Merck Company Detail
Table 68. Merck Business Overview
Table 69. Merck Parkinson's Disease Product
Table 70. Merck Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Boehringer Ingelheim Company Detail
Table 73. Boehringer Ingelheim Business Overview
Table 74. Boehringer Ingelheim Parkinson's Disease Product
Table 75. Boehringer Ingelheim Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
Table 76. Boehringer Ingelheim Recent Development
Table 77. Amneal + Impax Company Detail
Table 78. Amneal + Impax Business Overview
Table 79. Amneal + Impax Parkinson's Disease Product
Table 80. Amneal + Impax Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
Table 81. Amneal + Impax Recent Development
Table 82. Lundbeck Company Detail
Table 83. Lundbeck Business Overview
Table 84. Lundbeck Parkinson's Disease Product
Table 85. Lundbeck Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
Table 86. Lundbeck Recent Development
Table 87. Sun Pharma Company Detail
Table 88. Sun Pharma Business Overview
Table 89. Sun Pharma Parkinson's Disease Product
Table 90. Sun Pharma Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
Table 91. Sun Pharma Recent Development
Table 92. Wockhardt Company Detail
Table 93. Wockhardt Business Overview
Table 94. Wockhardt Parkinson's Disease Product
Table 95. Wockhardt Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
Table 96. Wockhardt Recent Development
Table 97. UCB Company Detail
Table 98. UCB Business Overview
Table 99. UCB Parkinson's Disease Product
Table 100. UCB Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
Table 101. UCB Recent Development
Table 102. Bausch Health Company Detail
Table 103. Bausch Health Business Overview
Table 104. Bausch Health Parkinson's Disease Product
Table 105. Bausch Health Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
Table 106. Bausch Health Recent Development
Table 107. Acadia Company Detail
Table 108. Acadia Business Overview
Table 109. Acadia Parkinson's Disease Product
Table 110. Acadia Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
Table 111. Acadia Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parkinson's Disease Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Parkinson's Disease Market Share by Type: 2022 VS 2033
Figure 3. Carbidopa/Levodopa Features
Figure 4. Dopamine Receptor Agonists Features
Figure 5. MAO-Inhibitors Features
Figure 6. Global Parkinson's Disease Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Parkinson's Disease Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Parkinson's Disease Report Years Considered
Figure 11. Global Parkinson's Disease Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Parkinson's Disease Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Parkinson's Disease Market Share by Region: 2022 VS 2033
Figure 14. Global Parkinson's Disease Market Share by Players in 2022
Figure 15. Global Top Parkinson's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Parkinson's Disease Revenue in 2022
Figure 17. North America Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Parkinson's Disease Market Share by Country (2018-2033)
Figure 19. United States Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Parkinson's Disease Market Share by Country (2018-2033)
Figure 23. Germany Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Parkinson's Disease Market Share by Region (2018-2033)
Figure 31. China Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Parkinson's Disease Market Share by Country (2018-2033)
Figure 39. Mexico Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Parkinson's Disease Market Share by Country (2018-2033)
Figure 43. Turkey Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Parkinson's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Teva Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
Figure 46. Novartis Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
Figure 47. GSK Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
Figure 48. AbbVie Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
Figure 49. Merck Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
Figure 50. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
Figure 51. Amneal + Impax Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
Figure 52. Lundbeck Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
Figure 53. Sun Pharma Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
Figure 54. Wockhardt Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
Figure 55. UCB Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
Figure 56. Bausch Health Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
Figure 57. Acadia Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed